Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
M Duijvestein, ACW Vos, H Roelofs, ME Wildenberg… - Gut, 2010 - gut.bmj.com
Background and aim Mesenchymal stromal cells (MSCs) are pluripotent cells that have
immunosuppressive effects both in vitro and in experimental colitis. Promising results of …
immunosuppressive effects both in vitro and in experimental colitis. Promising results of …
[HTML][HTML] Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study
GJ Tack, JMW Van de Water, MJ Bruins… - World journal of …, 2013 - ncbi.nlm.nih.gov
AIM: To assesses the safety and efficacy of Aspergillus niger prolyl endoprotease (AN-PEP)
to mitigate the immunogenic effects of gluten in celiac patients. METHODS: Patients with …
to mitigate the immunogenic effects of gluten in celiac patients. METHODS: Patients with …
[PDF][PDF] Chapter six Autologous bone marrow derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
BB Wendrich, HW Verspaget… - Gut, 2010 - scholarlypublications …
Background and aim: Mesenchymal stromal cells (MSCs) are pluripotent cells that have
immunosuppressive effects both in vitro and in experimental colitis. Promising results of …
immunosuppressive effects both in vitro and in experimental colitis. Promising results of …